Table 3.
Characteristics | n | SNORD1C |
p value | |
---|---|---|---|---|
high | low | |||
Total | 122 | 61 | 61 | |
Gender | 0.067 | |||
Male | 89 | 40 | 49 | |
female | 33 | 21 | 12 | |
Age (years) | 0.716 | |||
≤60 | 66 | 32 | 34 | |
>60 | 56 | 29 | 27 | |
Location | 0.102 | |||
Colon | 55 | 23 | 32 | |
Rectum | 67 | 38 | 29 | |
differentiation | 0.928 | |||
Well | 10 | 5 | 5 | |
moderate | 71 | 37 | 34 | |
Poor | 14 | 7 | 7 | |
unknown | 27 | 12 | 15 | |
Tumor infiltration | 0.039* | |||
T1-T2 | 25 | 10 | 15 | |
T3-T4 | 54 | 34 | 20 | |
unknown | 43 | 17 | 26 | |
Lymph node metastasis | 0.374 | |||
Yes | 35 | 14 | 21 | |
No | 65 | 35 | 30 | |
unknown | 22 | 12 | 10 | |
Venous invasion | 0.644 | |||
positive | 36 | 17 | 19 | |
negative | 61 | 33 | 28 | |
unknown | 25 | 11 | 14 | |
Nerve infiltration | 0.698 | |||
positive | 25 | 14 | 11 | |
negative | 72 | 36 | 36 | |
unknown | 25 | 11 | 14 | |
CEA (ng/ml) | 0.034* | |||
≤5 | 78 | 37 | 41 | |
>5 | 34 | 22 | 12 | |
unknown | 10 | 2 | 8 |
Note: *p < 0.05
TNM, tumor–lymph node metastasis; CEA, carcinoembryonic antigen